Skip to main content
Erschienen in: Medical Oncology 10/2014

01.10.2014 | Original Paper

MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population

verfasst von: Youchao Jia, Aimin Zang, Yanhong Shang, Hua Yang, Zizheng Song, Zhiyu Wang, Lili Ren, Yaning Wei, Ling Hu, Hongyun Shi, Hefei Li

Erschienen in: Medical Oncology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to investigate the association of single nucleotide polymorphisms (SNP) of the microRNA-146a (miR-146a) genes with the risk of nonsmall cell lung cancer (NSCLC). The genotyping of miR-146a rs2910164 polymorphism was detected by polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). The results showed that CC genotype and C allele distribution in the NSCLC patient were significantly higher than that of the controls (P = 0.03 and 0.03, respectively). No significant differences were found between the two subgroups when stratified by clinical characteristics including age, sexual, smoke status, histological type, lymph node metastasis and clinical stage. In addition, the expression of miR-146a was detected by the Taqman real-time PCR. It demonstrated that the miR-146a expression was significantly decreased in NSCLC patients compared with that of nonmalignant lung tissues (P = 0.01). In addition, the miR-146a expression of CC genotypes subgroup was significantly decreased than of GC/GG genotype subgroup in tumor tissues (P = 0.0022). It confirmed that the SNP rs2910164 could functionally affect the miR-146a expression levels. In conclusion, it showed that the rs2910164 polymorphism of miR-146a is associated with the risk of NSCLC in the Chinese population.
Literatur
1.
Zurück zum Zitat Dutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, et al. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS one. 2011;6(6):e20351.PubMedCrossRefPubMedCentral Dutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, et al. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS one. 2011;6(6):e20351.PubMedCrossRefPubMedCentral
2.
Zurück zum Zitat Wistuba II. Genetics of preneoplasia: lessons from lung cancer. Curr Mol Med. 2007;7(1):3–14.PubMedCrossRef Wistuba II. Genetics of preneoplasia: lessons from lung cancer. Curr Mol Med. 2007;7(1):3–14.PubMedCrossRef
3.
Zurück zum Zitat Cortinovis D, Monica V, Pietrantonio F, Ceresoli G, La Spina, Wannesson L. MicroRNAs in Non-Small Cell Lung Cancer: Current Status and Future Therapeutic Promises. Curr Pharm Des. 2014;20(24):3982–90. Cortinovis D, Monica V, Pietrantonio F, Ceresoli G, La Spina, Wannesson L. MicroRNAs in Non-Small Cell Lung Cancer: Current Status and Future Therapeutic Promises. Curr Pharm Des. 2014;20(24):3982–90.
4.
Zurück zum Zitat Jakopovic M, Thomas A, Balasubramaniam S, Schrump D, Giaccone G, Bates SE. Targeting the Epigenome in Lung Cancer: expanding Approaches to Epigenetic Therapy. Front Oncol. 2013;3:261.PubMedCrossRefPubMedCentral Jakopovic M, Thomas A, Balasubramaniam S, Schrump D, Giaccone G, Bates SE. Targeting the Epigenome in Lung Cancer: expanding Approaches to Epigenetic Therapy. Front Oncol. 2013;3:261.PubMedCrossRefPubMedCentral
5.
Zurück zum Zitat Schabath MB, Giuliano AR, Thompson ZJ, Amankwah EK, Gray JE, Fenstermacher DA, et al. TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. Carcinogenesis. 2013;34(11):2525–30.PubMedCrossRef Schabath MB, Giuliano AR, Thompson ZJ, Amankwah EK, Gray JE, Fenstermacher DA, et al. TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. Carcinogenesis. 2013;34(11):2525–30.PubMedCrossRef
6.
Zurück zum Zitat Ren YW, Yin ZH, Wan Y, Guan P, Wu W, Li XL, et al. P53 Arg72Pro and MDM2 SNP309 Polymorphisms Cooperate to Increase Lung Adenocarcinoma Risk in Chinese Female Non-smokers: a Case Control Study. Asian Pac J Cancer Prev. 2013;14(9):5415–20.PubMedCrossRef Ren YW, Yin ZH, Wan Y, Guan P, Wu W, Li XL, et al. P53 Arg72Pro and MDM2 SNP309 Polymorphisms Cooperate to Increase Lung Adenocarcinoma Risk in Chinese Female Non-smokers: a Case Control Study. Asian Pac J Cancer Prev. 2013;14(9):5415–20.PubMedCrossRef
7.
Zurück zum Zitat Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett. 2004;208(1):1–33.PubMedCrossRef Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett. 2004;208(1):1–33.PubMedCrossRef
8.
Zurück zum Zitat Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101(9):2999–3004.PubMedCrossRefPubMedCentral Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101(9):2999–3004.PubMedCrossRefPubMedCentral
9.
Zurück zum Zitat Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389–402.PubMedCrossRefPubMedCentral Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389–402.PubMedCrossRefPubMedCentral
10.
Zurück zum Zitat Akkız H, Bayram S, Bekar A, Akgöllü E, Usküdar O, Sandıkçı M. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case–control study. Gene. 2011;486(1–2):104–9.PubMedCrossRef Akkız H, Bayram S, Bekar A, Akgöllü E, Usküdar O, Sandıkçı M. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case–control study. Gene. 2011;486(1–2):104–9.PubMedCrossRef
11.
Zurück zum Zitat Qiu LX, He J, Wang MY, Zhang RX, Shi TY, Zhu ML, et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011;56(3):695–8.PubMedCrossRef Qiu LX, He J, Wang MY, Zhang RX, Shi TY, Zhu ML, et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011;56(3):695–8.PubMedCrossRef
12.
Zurück zum Zitat Jeon HS, Lee YH, Lee SY, Jang JA, Choi YY, Yoo SS, et al. A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene. 2014;534(1):66–71.PubMedCrossRef Jeon HS, Lee YH, Lee SY, Jang JA, Choi YY, Yoo SS, et al. A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene. 2014;534(1):66–71.PubMedCrossRef
13.
Zurück zum Zitat Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L, et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med. 2011;49(12):2073–80.PubMedCrossRef Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L, et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med. 2011;49(12):2073–80.PubMedCrossRef
14.
Zurück zum Zitat Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk (Phila). Cancer Prev Res. 2008;1:460–9.CrossRef Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk (Phila). Cancer Prev Res. 2008;1:460–9.CrossRef
15.
Zurück zum Zitat Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–31.PubMedCrossRef Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–31.PubMedCrossRef
16.
Zurück zum Zitat Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA. 2009;106:1502–5.PubMedCrossRefPubMedCentral Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA. 2009;106:1502–5.PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009;69:1279–83.PubMedCrossRefPubMedCentral Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009;69:1279–83.PubMedCrossRefPubMedCentral
18.
Zurück zum Zitat Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008;105:7269–74.PubMedCrossRefPubMedCentral Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008;105:7269–74.PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144(4):794–807.PubMedCrossRef Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144(4):794–807.PubMedCrossRef
Metadaten
Titel
MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population
verfasst von
Youchao Jia
Aimin Zang
Yanhong Shang
Hua Yang
Zizheng Song
Zhiyu Wang
Lili Ren
Yaning Wei
Ling Hu
Hongyun Shi
Hefei Li
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 10/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0194-2

Weitere Artikel der Ausgabe 10/2014

Medical Oncology 10/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.